Celebrity Race Across the World contestant Anita Rani wants to live life on her own terms. (Photo illustration: Yahoo Life UK; photo: Mike Marsland/Getty Images) Grounded, family-orientated and ...

Just two years following the breakdown of her 14 year marriage, Countryfile presenter Anita Rani has shared details of her new relationship with Alex Lavery. The couple went public in September this ...

The 48-year-old shared intimate details of her dating life, she said: 'He’s not just good-looking, he’s a beautiful soul. He’s free-spirited and has really great energy.' Anita has a huge passion for ...

10:55, Sun, Nov 30, 2025 Updated: 11:11, Sun, Nov 30, 2025 Countryfile presenter Anita Rani has revealed she's reluctant to "jinx" her blossoming romance whilst confessing she'd contemplate walking ...

Countryfile star Anita Rani says she doesn’t want to “jinx” her new relationship as she admits she would consider tying the knot with her new boyfriend. Anita, 48, split from ex-husband Bhupi Rehal in ...

From ghost-story minimalism to wartime memory, Rani’s two new works, premiered here, shimmer with imagination, although issues of balance diminished the piano concerto In a crowded post-minimalist ...

Rani Therapeutics Holdings, Inc. targets a new potential oral delivery of biologic drugs via the RaniPill. This could eventually replace injections and improve patient adherence. Their pipeline has RT ...

The company will receive an upfront payment of $10 million. It could also earn up to $75 million in development milestones, $100 million in sales milestones, and single-digit royalties on future ...

The collaboration aims to develop an oral product combining Rani’s RaniPill technology with Chugai’s rare disease antibody. Notably, Chugai has options to extend rights to up to five additional drug ...

Shares of Rani Therapeutics Holdings have doubled, to $1.12, in premarket trading after the company said it has entered into a collaboration and license agreement with Chugai Pharmaceutical. The ...

SAN JOSE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral ...

SAN JOSE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral ...